International Patent: INHIBITING APE2 EXPRESSION IN INJURED OR DISEASED BRAINS

GENEVA, Sept. 24 -- THE CLEVELAND CLINIC FOUNDATION filed a patent application (US2026/020044) for “INHIBITING APE2 EXPRESSION IN INJURED OR DISEASED BRAINS”. With publication no. WO/2026/198845, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: A61K 31/713

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....